Phenylalanine Amide

Phenylalanine Amide

SCHEMBL16001479

[2H]NC(Cc1ccccc1)C(N)=O

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALPI P09923 1/20 0.60
▸ PKM P14618 1/20 0.60
▸ PTGS1 P23219 1/20 0.60
▸ XIAP P98170 1/20 0.60
▸ SLC7A5 Q01650 1/20 0.60
▸ EPHX1 P07099 1/20 0.55
▸ SLC15A1 P46059 1/20 0.51
▸ LTA4H P09960 2/20 0.49
▸ CYP1A2 P05177 1/20 0.48
▸ SLC1A3 P43003 2/20 0.47
▸ SLC1A2 P43004 2/20 0.47
▸ SLC1A1 P43005 2/20 0.47
▸ HDAC8 Q9BY41 2/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ POLB P06746 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ SRR Q9GZT4 2/20 0.46
▸ MDM2 Q00987 1/20 0.44
▸ CTSC P53634 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenylalanine Amide SCHEMBL16001480 1.00 ALPI (0.60) ALPIPKMPTGS1XIAPSLC7A5
Dl-Phenylalanine SCHEMBL3439692 0.86 SLC7A5 (0.74) ALPIPKMPTGS1XIAPSLC7A5
Dl-Phenylalanine SCHEMBL2939606 0.86 SLC7A5 (0.74) ALPIPKMPTGS1XIAPSLC7A5
Phenylalanine Amide SCHEMBL353251 0.86 SLC7A5 (0.73) ALPIPKMPTGS1XIAPSLC7A5
Phenylalanine Amide SCHEMBL11349868 0.86 SLC7A5 (0.73) ALPIPKMPTGS1XIAPSLC7A5
Phenylalanine Amide SCHEMBL244302 0.86 SLC7A5 (0.73) ALPIPKMPTGS1XIAPSLC7A5
Phenylalanine Amide SCHEMBL244303 0.86 SLC7A5 (0.73) ALPIPKMPTGS1XIAPSLC7A5
Phenylalanine Amide SCHEMBL23002157 0.84 SLC7A5 (0.70) ALPIPKMPTGS1XIAPSLC7A5
Phenylalanine Amide SCHEMBL7613303 0.84 SLC7A5 (0.70) ALPIPKMPTGS1XIAPSLC7A5
Phenylalanine Amide SCHEMBL11569548 0.84 SLC7A5 (0.70) ALPIPKMPTGS1XIAPSLC7A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9453063-B2 Hybrid polypeptides with selectable properties AMYLIN PHARMACEUTICALS, LLC. (US) 2016-09-27 — — US disclosed
US-20140249299-A1 HYBRID POLYPEPTIDES WITH SELECTABLE PROPERTIES ASTRAZENECA PHARMACEUTICALS LP (US) 2014-09-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140249299-A1 HYBRID POLYPEPTIDES WITH SELECTABLE PROPERTIES IAPP, IGFBP1, PGF ALPI 2908/4885PKM 3000/4885PTGS1 1505/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback